FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Miguel Navarro

Research Profile

Living Beings

Activities & Behaviors

Concepts & Ideas

Drug Dose Response Relationship

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Francisco Alén; Raquel Gómez; Gustavo González-Cuevas; Miguel Navarro; José Antonio López-Moreno
Nicotine causes opposite effects on alcohol intake: Evidence in an animal experimental model of abstinence and relapse from alcohol.
Guillermo Moreno-Sanz; Esther O'Shea; Laura Orio; Isabel Escobedo; Gustavo González-Cuevas; Miguel Navarro; Maria Isabel Colado; José Antonio López-Moreno
Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.
F Alén; Angel Santos; G Moreno-Sanz; Gustavo González-Cuevas; E Giné; L Franco-Ruiz; Miguel Navarro; José Antonio López-Moreno
Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Miguel Navarro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Francisco Alén; Raquel Gómez; Gustavo González-Cuevas; Miguel Navarro; José Antonio López-Moreno
Nicotine causes opposite effects on alcohol intake: Evidence in an animal experimental model of abstinence and relapse from alcohol.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2009;11(11):1304-11.
2009: Guillermo Moreno-Sanz; Esther O'Shea; Laura Orio; Isabel Escobedo; Gustavo González-Cuevas; Miguel Navarro; Maria Isabel Colado; José Antonio López-Moreno
Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(7):929-40.
2009: F Alén; Angel Santos; G Moreno-Sanz; Gustavo González-Cuevas; E Giné; L Franco-Ruiz; Miguel Navarro; José Antonio López-Moreno
Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors.
Neuroscience 2009;158(2):465-73.
2008: Francisco Alen; Guillermo Moreno-Sanz; Ana Isabel de Tena; Rayna D Brooks; Alejandro López-Jimenez; Miguel Navarro; José Antonio López-Moreno
Pharmacological activation of CB1 and D2 receptors in rats: predominant role of CB1 in the increase of alcohol relapse.
The European journal of neuroscience 2008;27(12):3292-8.
2008: José Antonio López-Moreno; Gustavo González-Cuevas; Guillermo Moreno; Miguel Navarro
The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
Addiction biology 2008;13(2):160-87.
2008: Ana Belén Martín; Emilio Fernandez Espejo; Belén Ferrer; Miguel Angel Gorriti; Ainhoa Bilbao; Miguel Navarro; Fernando Rodriguez de Fonseca; Rosario Moratalla
Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1667-79.
2008: Teresa Asúa; Ainhoa Bilbao; Miguel Angel Gorriti; Jose Antonio Lopez-Moreno; Maria Del Mar Alvarez; Miguel Navarro; Fernando Rodríguez de Fonseca; Ana Perez-Castillo; Angel Santos
Implication of the endocannabinoid system in the locomotor hyperactivity associated with congenital hypothyroidism.
Endocrinology 2008;149(5):2657-66.
2008: José Antonio López-Moreno; María Scherma; Fernando Rodríguez de Fonseca; Gustavo González-Cuevas; Walter Fratta; Miguel Navarro
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2.
Neuroscience letters 2008;433(1):1-5.
2008: Inmaculada Crespo; Raquel Gómez de Heras; Fernando Rodríguez de Fonseca; Miguel Navarro
Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1.
Neuropharmacology 2008;54(1):219-25.
2007: Gustavo González-Cuevas; Harinder Aujla; Rémi Martin-Fardon; José Antonio López-Moreno; Miguel Navarro; Friedbert Weiss
Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(11):2260-6.
2007: Andrea Cippitelli; Ainhoa Bilbao; Miguel Angel Gorriti; Miguel Navarro; Maurizio Massi; Daniele Piomelli; Roberto Ciccocioppo; Fernando Rodríguez de Fonseca
The anandamide transport inhibitor AM404 reduces ethanol self-administration.
The European journal of neuroscience 2007;26(2):476-86.
2007: Belen Ferrer; Francisco Javier Bermúdez-Silva; Ainhoa Bilbao; Lily Alvarez-Jaimes; Irene Sanchez-Vera; Andrea Giuffrida; Antonia Serrano; Elena Baixeras; Satishe Khaturia; Miguel Navarro; Loren H Parsons; Daniele Piomelli; Fernando Rodríguez de Fonseca
Regulation of brain anandamide by acute administration of ethanol.
The Biochemical journal 2007;404(1):97-104.
2007: Belen Ferrer; Miguel Angel Gorriti; Ana Palomino; Isolde Gornemann; Yolanda De diego Otero; Francisco Javier Bermudez-Silva; Ainhoa Bilbao; Emilio Fernandez Espejo; Rosario Moratalla; Miguel Navarro; Fernando Rodríguez de Fonseca
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
European journal of pharmacology 2007;559(2-3):180-3.
2007: José Antonio López-Moreno; Gustavo González-Cuevas; Miguel Navarro
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
Neurobiology of disease 2007;25(2):274-83.
2006: Francisco Javier Pavon; Ainhoa Bilbao; Laura Hernández-Folgado; Andrea Cippitelli; Nadine Jagerovic; Gumersindo Abellán; M A Isabel Rodríguez-Franco; Antonia Serrano; Manuel Macias; Raquel Gómez; Miguel Navarro; Pilar Goya; Fernando Rodríguez de Fonseca
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
Neuropharmacology 2006;51(2):358-66.
2006: Ainhoa Bilbao; Andrea Cippitelli; Ana B Martín; Noelia Granado; Oskar Ortiz; Erwan Bezard; Jiang-Fan Chen; Miguel Navarro; Fernando Rodríguez de Fonseca; Rosario Moratalla
Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
Psychopharmacology 2006;185(2):160-8.
2005: Margarita Moreno; J A Lopez-Moreno; Fernando Rodríguez de Fonseca; Miguel Navarro
Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats.
Behavioural pharmacology 2005;16(5-6):441-6.
2005: Margarita Moreno; Leticia Escuredo; R Muñoz; F Rodriguez de Fonseca; Miguel Navarro
Long-term behavioural and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors.
Behavioural pharmacology 2005;16(5-6):423-30.
2005: Esther O'Shea; Isabel Escobedo; Laura Orio; Veronica Sanchez; Miguel Navarro; A Richard Green; M Isabel Colado
Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(7):1312-23.
2005: Miguel Angel Gorriti; Belen Ferrer; Ignacio Del Arco; Francisco Javier Bermúdez-Silva; Yolanda De diego Otero; Emilio Fernandez Espejo; Miguel Navarro; Fernando Rodríguez de Fonseca
Acute delta9-tetrahydrocannabinol exposure facilitates quinpirole-induced hyperlocomotion.
Pharmacology, biochemistry, and behavior 2005;81(1):71-7.
2005: Andrea Cippitelli; Ainhoa Bilbao; Anita C Hansson; Ignacio Del Arco; Wolfgang Sommer; Markus Heilig; Maurizio Massi; Francisco Javier Bermúdez-Silva; Miguel Navarro; Roberto Ciccocioppo; Fernando Rodríguez de Fonseca
Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
The European journal of neuroscience 2005;21(8):2243-51.
2005: Fernando Rodríguez de Fonseca; Ignacio Del Arco; Francisco Javier Bermudez-Silva; Ainhoa Bilbao; Andrea Cippitelli; Miguel Navarro
The endocannabinoid system: physiology and pharmacology.
Alcohol and alcoholism (Oxford, Oxfordshire) 2005;40(1):2-14.
2004: José Antonio López-Moreno; J M Trigo-Díaz; Fernando Rodríguez de Fonseca; Gustavo González-Cuevas; R Gómez de Heras; I Crespo Galán; Miguel Navarro
Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatement.
Neuropharmacology 2004;47(7):1036-44.
2004: Miguel Navarro; M Rocío A Carrera; Ignacio Del Arco; Jose Manuel Trigo; George F Koob; Fernando Rodríguez de Fonseca
Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats.
European journal of pharmacology 2004;501(1-3):235-7.
2004: José Antonio López-Moreno; Gustavo González-Cuevas; Fernando Rodríguez de Fonseca; Miguel Navarro
Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(38):8245-52.
2004: Carmen Manzanedo; María A Aguilar; Marta Rodríguez-Arias; Miguel Navarro; José Miñarro
Cannabinoid agonist-induced sensitisation to morphine place preference in mice.
Neuroreport 2004;15(8):1373-7.
2004: Nadine Jagerovic; Laura Hernandez-Folgado; Ibon Alkorta; Pilar Goya; Miguel Navarro; Antonia Serrano; Fernando Rodriguez de Fonseca; María Teresa Dannert; Angela Alsasua; Margarita Suardiaz; David Pascual; María Isabel Martín
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif.
Journal of medicinal chemistry 2004;47(11):2939-42.
2004: Carmen Manzanedo; María A Aguilar; Marta Rodríguez-Arias; Miguel Navarro; José Miñarro
7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine.
Behavioural brain research 2004;150(1-2):73-82.
2003: Margarita Moreno; Jose Manuel Trigo; Leticia Escuredo; Fernando Rodríguez de Fonseca; Miguel Navarro
Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats.
Pharmacology, biochemistry, and behavior 2003;75(3):565-75.
2002: Raquel Gómez; Miguel Navarro; Belen Ferrer; Jose Manuel Trigo; Ainhoa Bilbao; Ignacio Del Arco; Andrea Cippitelli; Felice Nava; Daniele Piomelli; Fernando Rodríguez de Fonseca
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(21):9612-7.
2002: Ignacio Del Arco; Miguel Navarro; Ainhoa Bilbao; Belen Ferrer; Daniele Piomelli; Fernando Rodríguez de Fonseca
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404.
European journal of pharmacology 2002;454(1):103-4.
2001: Fernando Rodríguez de Fonseca; Miguel Navarro; Raquel Gómez; Leticia Escuredo; Felice Nava; Jin Fu; E Murillo-Rodríguez; Andrea Giuffrida; Jesse LoVerme; Silvana Gaetani; Satish Kathuria; C Gall; Daniele Piomelli
An anorexic lipid mediator regulated by feeding.
Nature 2001;414(6860):209-12.
2001: Miguel Navarro; M Rocío A Carrera; Walter Fratta; O Valverde; Gregorio Cossu; Liana Fattore; Julie A Chowen; R Gomez; Ignacio Del Arco; MA Villanua; Rafael Maldonado; George F Koob; F Rodriguez de Fonseca
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(14):5344-50.
2001: Fernando Rodríguez de Fonseca; Miguel Angel Gorriti; Ainhoa Bilbao; Leticia Escuredo; Luis Miguel García-Segura; Daniele Piomelli; Miguel Navarro
Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia.
Neurotoxicity research 2001;3(1):23-35.
2000: F Rodriquez de Fonseca; Miguel Navarro; Elvira Alvarez; Isabel Roncero; Julie A Chowen; O Maestre; R Gómez; RM Muñoz; J Eng; Enrique Blázquez
Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Metabolism: clinical and experimental 2000;49(6):709-17.
2000: Ignacio Del Arco; R Muñoz; Fernando Rodríguez de Fonseca; L Escudero; JL Martín-Calderón; Miguel Navarro; M Angeles Villanúa
Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.
Neuroimmunomodulation 2000;7(1):16-26.
1999: Fernando Rodríguez de Fonseca; A J Roberts; Ainhoa Bilbao; George F Koob; Miguel Navarro
Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
Zhongguo yao li xue bao = Acta pharmacologica Sinica 1999;20(12):1109-14.
1999: Fernando Rodríguez de Fonseca; Tibor Wenger; Miguel Navarro; L L Murphy
Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
Brain research 1999;841(1-2):114-22.
1999: Julie A Chowen; F R de Fonseca; E Alvarez; Miguel Navarro; Luis Miguel García-Segura; Enrique Blázquez
Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain.
Neuropeptides 1999;33(3):212-5.
1999: Miguel Angel Gorriti; Fernando Rodríguez de Fonseca; Miguel Navarro; Tomas Palomo
Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats.
European journal of pharmacology 1999;365(2-3):133-42.
1998: Fernando Rodríguez de Fonseca; Ignacio Del Arco; JL Martín-Calderón; Miguel Angel Gorriti; Miguel Navarro
Role of the endogenous cannabinoid system in the regulation of motor activity.
Neurobiology of disease 1998;5(6 Pt B):483-501.
1998: Miguel Navarro; Fernando Rodríguez de Fonseca
The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.
Neurobiology of disease 1998;5(6 Pt B):379-85.
1998: P Rubio; Fernando Rodríguez de Fonseca; JL Martín-Calderón; Ignacio Del Arco; S Bartolomé; M Angeles Villanúa; Miguel Navarro
Maternal exposure to low doses of delta9-tetrahydrocannabinol facilitates morphine-induced place conditioning in adult male offspring.
Pharmacology, biochemistry, and behavior 1998;61(3):229-38.
1998: Miguel Navarro; Julie A Chowen; M Rocío A Carrera; Ignacio Del Arco; M Angeles Villanúa; Y Martin; A J Roberts; George F Koob; Fernando Rodríguez de Fonseca
CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.
Neuroreport 1998;9(15):3397-402.
1998: Enrique Blázquez; Elvira Alvarez; Miguel Navarro; Isabel Roncero; F Rodríguez-Fonseca; Julie A Chowen; José Antonio Zueco
Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.
Molecular neurobiology 1998;18(2):157-73.
1998: JL Martín-Calderón; RM Muñoz; M Angeles Villanúa; Ignacio Del Arco; J L Moreno; Fernando Rodríguez de Fonseca; Miguel Navarro
Characterization of the acute endocrine actions of (-)-11-hydroxy-delta8-tetrahydrocannabinol-dimethylheptyl (HU-210), a potent synthetic cannabinoid in rats.
European journal of pharmacology 1998;344(1):77-86.
1997: Fernando Rodríguez de Fonseca; M Rocío A Carrera; Miguel Navarro; George F Koob; F Weiss
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
Science (New York, N.Y.) 1997;276(5321):2050-4.
1997: Miguel Navarro; E Hernández; RM Muñoz; Ignacio Del Arco; M Angeles Villanúa; M Rocío A Carrera; Fernando Rodríguez de Fonseca
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
Neuroreport 1997;8(2):491-6.
1996: Miguel Navarro; Rosario De Miguel; Fernando Rodríguez de Fonseca; José A Ramos; Javier Fernández-Ruiz
Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats.
Behavioural brain research 1996;75(1-2):91-8.
1996: Fernando Rodríguez de Fonseca; P Rubio; F Menzaghi; E Merlo-Pich; J Rivier; George F Koob; Miguel Navarro
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
The Journal of pharmacology and experimental therapeutics 1996;276(1):56-64.
1995: Miguel Navarro; P Rubio; Fernando Rodríguez de Fonseca
Behavioural consequences of maternal exposure to natural cannabinoids in rats.
Psychopharmacology 1995;122(1):1-14.
1995: Fernando Rodríguez de Fonseca; M Angeles Villanúa; RM Muñoz; O San-Martin-Clark; Miguel Navarro
Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats.
Neuroendocrinology 1995;61(6):714-21.
1995: Fernando Rodríguez de Fonseca; P Rubio; JL Martín-Calderón; S B Caine; George F Koob; Miguel Navarro
The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference.
European journal of pharmacology 1995;274(1-3):47-55.
1995: P Rubio; Fernando Rodríguez de Fonseca; RM Muñoz; C Ariznavarreta; JL Martín-Calderón; Miguel Navarro
Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis.
Life sciences 1995;56(23-24):2169-76.
1994: Miguel Navarro; P Rubio; Fernando Rodríguez de Fonseca
Sex-dimorphic psychomotor activation after perinatal exposure to (-)-delta 9-tetrahydrocannabinol. An ontogenic study in Wistar rats.
Psychopharmacology 1994;116(4):414-22.
1994: Fernando Rodríguez de Fonseca; JL Martín-Calderón; R Mechoulam; Miguel Navarro
Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.
Neuroreport 1994;5(7):761-5.
1994: Miguel Navarro; Fernando Rodríguez de Fonseca; ML Hernández; José A Ramos; Javier Fernández-Ruiz
Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids.
Pharmacology, biochemistry, and behavior 1994;47(1):47-58.
1994: ML Hernández; Javier Fernández-Ruiz; Miguel Navarro; Rosario De Miguel; Maribel Cebeira; L Vaticón; José A Ramos
Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.
Journal of neural transmission. General section 1994;96(1):63-79.
1993: Miguel Navarro; Javier Fernández-Ruiz; Rosario De Miguel; ML Hernández; Maribel Cebeira; José A Ramos
An acute dose of delta 9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity.
Behavioural brain research 1993;57(1):37-46.
1993: Miguel Navarro; Javier Fernández-Ruiz; Rosario De Miguel; ML Hernández; Maribel Cebeira; José A Ramos
Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations.
Pharmacology, biochemistry, and behavior 1993;45(2):291-8.
1992: Miguel Navarro; Javier Fernández-Ruiz; F Rodriguez de Fonseca; ML Hernández; Maribel Cebeira; José A Ramos
Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice.
Pharmacology, biochemistry, and behavior 1992;43(2):603-8.
1991: Miguel Navarro; Juan C Leza; ignacio lizasoain; Pedro Lorenzo
Influence of psychogenetics in opiate tolerance and abstinence in mice.
General pharmacology 1991;22(4):713-6.
1991: Fernando Rodríguez de Fonseca; Maribel Cebeira; Javier Fernández-Ruiz; Miguel Navarro; José A Ramos
Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons.
Neuroscience 1991;43(2-3):713-23.